Nectar Lifescience Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 22.43 | 22.43 | 22.43 | 22.43 | 22.43 |
Reserves | 1,046.83 | 1,042.17 | 1,064.44 | 1,038.31 | 1,112.18 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,069.26 | 1,064.60 | 1,086.87 | 1,060.74 | 1,134.61 |
Secured Loans | 539.53 | 672.39 | 783.85 | 825.42 | 760.31 |
Unsecured Loans | 96.01 | 81.44 | 76.08 | 77.99 | 18.45 |
Total Debt | 635.54 | 753.83 | 859.93 | 903.41 | 778.76 |
Other Liabilities | 8.68 | 7.22 | 8.02 | 10.45 | 11.33 |
Total Liabilities | 1,713.48 | 1,825.65 | 1,954.82 | 1,974.60 | 1,924.70 |
APPLICATION OF FUNDS : | |||||
Gross Block | 1,599.41 | 1,557.96 | 1,562.95 | 1,555.70 | 1,508.81 |
Less: Accumulated Depreciation | 956.70 | 895.99 | 839.85 | 783.81 | 723.96 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 642.71 | 661.97 | 723.10 | 771.89 | 784.85 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 65.75 | 77.78 | 85.10 | 98.63 | 115.00 |
Investments | 0.74 | 0.56 | 1.03 | 1.03 | 0.74 |
Current Assets, Loans & Advances | |||||
Inventories | 709.15 | 672.60 | 659.77 | 586.97 | 975.13 |
Sundry Debtors | 379.19 | 279.61 | 446.98 | 374.59 | 396.87 |
Cash and Bank Balance | 19.80 | 17.57 | 17.74 | 25.43 | 21.23 |
Loans and Advances | 175.19 | 261.09 | 228.81 | 250.12 | 220.27 |
Total Current Assets | 1,283.34 | 1,230.86 | 1,353.29 | 1,237.11 | 1,613.51 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 475.36 | 361.71 | 433.20 | 410.61 | 585.02 |
Provisions | 2.22 | 1.86 | 1.70 | 1.61 | 5.59 |
Total CL & Provisions | 477.58 | 363.57 | 434.90 | 412.22 | 590.61 |
Net Current Assets | 805.76 | 867.29 | 918.40 | 824.89 | 1,022.90 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 140.42 | 155.15 | 133.07 | 139.53 | 8.36 |
Deferred Tax Liability | 132.95 | 134.58 | 130.64 | 127.63 | 125.21 |
Net Deferred Tax | 7.47 | 20.57 | 2.43 | 11.90 | -116.85 |
Other Assets | 191.06 | 197.47 | 224.75 | 266.26 | 118.07 |
Total Assets | 1,713.49 | 1,825.65 | 1,954.81 | 1,974.60 | 1,924.71 |
Contingent Liabilities | 214.14 | 163.02 | 75.65 | 89.49 | 71.67 |